Education
About Us
Working with TipRanks
Follow Us
QuidelOrtho (QDEL)
NASDAQ:QDEL
QDEL Stock Chart & Stats
$20.99
-$1.26(-2.69%)
At close: 4:00 PM EST
$20.99
-$1.26(-2.69%)
Day’s Range― - ―
52-Week Range$19.50 - $49.45
Previous CloseN/A
Volume114.08K
Average Volume (3M)1.55M
Market Cap
$1.43B
Enterprise Value$4.67B
Total Cash (Recent Filing)$98.10M
Total Debt (Recent Filing)$2.84B
Price to Earnings (P/E)―
Beta1.27
Next Earnings
Feb 18, 2026EPS Estimate
0.42Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.80
Shares Outstanding67,931,540
10 Day Avg. Volume2,391,598
30 Day Avg. Volume1,550,569
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.99
Price to Sales (P/S)1.06
P/FCF Ratio-26.38
Enterprise Value/Market Cap3.28
Enterprise Value/Revenue1.72
Enterprise Value/Gross Profit3.01
Enterprise Value/Ebitda-9.02
Forecast
1Y Price Target
$34.60Price Target Upside64.84% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
EPS Forecast (FY)2.12
Revenue Forecast (FY)$2.71B
Bulls Say, Bears Say
Bulls Say
Cost SavingsThe team is delivering on both revenue and margin targets, and savings are showing up.
Margin ImprovementContinued operating expense discipline led to AEBITDA margins of 25% versus consensus at 21%.
Revenue PerformanceRevenue beat consensus by 5%, with beats from both respiratory and non-respiratory revenue.
Bears Say
Geopolitical RiskA policy in China was announced that is believed to add incremental risk to the stock, causing shares to trade down as the news spread.
Interest ExpenseThe interest rate on the company’s debt will increase from an annual rate of roughly 6% to a rate of roughly 7%, resulting in an additional $20 million to $25 million in annualized interest expense.
Margin PressureAEBITDA margins will take a dip in the fourth quarter due to a higher mix of instrument sales, incentive compensation, and R&D expenses.
QuidelOrtho News
QDEL FAQ
What was QuidelOrtho’s price range in the past 12 months?
QuidelOrtho lowest stock price was $19.50 and its highest was $49.45 in the past 12 months.
What is QuidelOrtho’s market cap?
QuidelOrtho’s market cap is $1.43B.
When is QuidelOrtho’s upcoming earnings report date?
QuidelOrtho’s upcoming earnings report date is Feb 18, 2026 which is in 89 days.
How were QuidelOrtho’s earnings last quarter?
QuidelOrtho released its earnings results on Nov 05, 2025. The company reported $0.8 earnings per share for the quarter, beating the consensus estimate of $0.515 by $0.285.
Is QuidelOrtho overvalued?
According to Wall Street analysts QuidelOrtho’s price is currently Undervalued.
Does QuidelOrtho pay dividends?
QuidelOrtho does not currently pay dividends.
What is QuidelOrtho’s EPS estimate?
QuidelOrtho’s EPS estimate is 0.42.
How many shares outstanding does QuidelOrtho have?
QuidelOrtho has 67,931,540 shares outstanding.
What happened to QuidelOrtho’s price movement after its last earnings report?
QuidelOrtho reported an EPS of $0.8 in its last earnings report, beating expectations of $0.515. Following the earnings report the stock price went down -22.324%.
Which hedge fund is a major shareholder of QuidelOrtho?
Currently, no hedge funds are holding shares in QDEL
QuidelOrtho Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$34.60 (64.84% Upside)
$34.60 (64.84% Upside)
Blogger Sentiment
Bullish
QDEL Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 19.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.1%
Last 30 Days ▲ 1.6%
Last 30 Days ▲ 1.6%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-45.59%
12-Months-Change
Fundamentals
Return on Equity
-44.21%
Trailing 12-Months
Asset Growth
-16.56%
Trailing 12-Months
Company Description
QuidelOrtho
QuidelOrtho Corporation is a leading provider of diagnostic solutions, specializing in medical devices and innovative technologies that enhance patient care. The company operates primarily in the infectious disease, women's health, and respiratory sectors, offering a range of products that include rapid diagnostic tests, assays, and molecular diagnostic systems. QuidelOrtho's core mission is to empower healthcare providers with tools that facilitate timely and accurate diagnoses, thereby improving patient outcomes across various healthcare settings.
QDEL Company Deck
QDEL Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call showcased a strong performance in organic sales growth, cost savings, and regional successes, despite challenges from declining COVID and donor screening revenues, negative cash flow due to system conversion, and a significant goodwill impairment charge.View all QDEL earnings summariesQDEL Stock 12 Month Forecast
Average Price Target
$34.60
▲(64.84% Upside)
Technical Analysis
Ownership Overview
Currently, No data available
---